You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (34) |
Back to Search
Expansion of a Levonorgestrel Physiologically-Based Pharmacokinetic Model (PBPK) to Evaluate the Pharmacokinetic/Pharmacodynamic (PKPD) Effects of SHBG Protein Binding
- At: PSWC2020 (2020)
- Type: Poster
- By: CICALI, Brian (United States)
- Co-author(s): Brian Cicali: Center for Pharmacometrics and Systems Pharmacology, University of Florida, Orlando, United States
Rodrigo Cristofoletti: Center for Pharmacometrics and Systems Pharmacology, University of Florida, Orlando, United States
Thomas Wendl: Bayer AG, Leverkusen, Germany
Karthik Lingineni: Center for Pharmacometrics and Systems Pharmacology, University of Florida, Orlando, United States
Joachim Hoechel: Bayer AG, Leverkusen, Germany
Herbert Wiesinger: Bayer AG, Leverkusen, Germany
Valvanera Vozmediano: Center for Pharmacometrics and Systems Pharmacology, University of Florida, Orlando, United States
Stephan Schmidt: Center for Pharmacometrics and Systems Pharmacology, University of Florida, Orlando, United States - Abstract:
Background
PBPK modeling is traditionally used to evaluate PK interactions. In this work we seek to expand this traditional framework to include PD interactions using hormonal contraceptives and protein binding dynamics. Levonorgestrel (LNG) and ethinyl estradiol (EE) are common hormonal contraceptives used globally. Sex-Hormone Binding Globulin.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026